Mimedx (MDXG) Other Accumulated Expenses (2011 - 2026)

Mimedx (MDXG) has 16 years of Other Accumulated Expenses data on file, last reported at $6.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 36.51% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 36.51% YoY), and the FY2025 full-year result was $5.8 million, up 28.47% from the prior year.
• Other Accumulated Expenses grew to $6.1 million in Q1 2026, from $5.8 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $6.1 million in Q1 2026 to a low of $1.6 million in Q1 2022.
• A 5-year average of $3.1 million and a median of $2.6 million in 2024 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses slipped 6.04% in 2022 and jumped 126.92% in 2024, its largest moves.
• Tracing MDXG's Other Accumulated Expenses over 5 years: stood at $1.8 million in 2022, then soared by 57.8% to $2.9 million in 2023, then jumped by 55.74% to $4.5 million in 2024, then climbed by 28.47% to $5.8 million in 2025, then climbed by 4.56% to $6.1 million in 2026.
• Business Quant data shows MDXG's Other Accumulated Expenses at $6.1 million in Q1 2026, $5.8 million in Q4 2025, and $4.4 million in Q3 2025.